Trial Profile
A Prospective Randomized Placebo Controlled Study to Evaluate the Effect of Celecoxib on the Efficacy and Safety of Amlodipine on Renal and Vascular Function in Subjects With Existing Hypertension Requiring Antihypertensive Therapy
Status:
Completed
Phase of Trial:
Phase III/IV
Latest Information Update: 27 Oct 2021
Price :
$35
*
At a glance
- Drugs Amlodipine (Primary) ; Celecoxib (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- Sponsors Kitov Pharmaceuticals; Purple Biotech
- 26 Oct 2017 According to a Kitov Pharmaceuticals media release, primary endpoint has been met. (Mean reduction in average daytime (9:00 to 21:00) ambulatory systolic blood pressure (SBPday))
- 26 Oct 2017 Results published in a Kitov Pharmaceuticals Media Release.
- 31 Jul 2017 Status changed from recruiting to completed.